Superselective transarterial chemoembolization vs hepatic resection for resectable early-stage hepatocellular carcinoma in patients with Child-Pugh class a liver function

European Journal of Radiology

Volumn 81, Issue 3, 2012, Pages 466-471

  Hsu, Kuo Feng ^a   Chu, Chi Hung ^a   Chan, De Chuan ^a   Yu, Jyh Cherng ^a   Shih, Ming Lang ^a   Hsieh, Huan Fa ^a,b   Hsieh, Tsai Yuan ^a   Yu, Chih Yung ^a   Hsieh, Chung Bao ^a  

^a TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^b Yee Zen General Hospital   (Taiwan)

Author keywords

Barcelona Clinic Liver Cancer Classification; Hepatectomy; Hepatocellular carcinoma; Survival; Transarterial chemoembolization

Indexed keywords

DOXORUBICIN; IODINATED POPPYSEED OIL; SERUM ALBUMIN;

ABDOMINAL ABSCESS; ABDOMINAL PAIN; ACUTE PANCREATITIS; ADULT; ARTICLE; BLEEDING; BRAIN DISEASE; CANCER MORTALITY; CANCER RECURRENCE; CHEMOEMBOLIZATION; CONTROLLED STUDY; EARLY CANCER; FEMALE; FEVER; FOLLOW UP; HUMAN; INTERMETHOD COMPARISON; LIVER ABSCESS; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FUNCTION; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; NAUSEA; PLEURA EFFUSION; PNEUMONIA; PRIORITY JOURNAL; RISK FACTOR; STOMACH ULCER; SURVIVAL TIME; TRANSARTERIAL CHEMOEMBOLIZATION; TREATMENT OUTCOME; TUMOR VOLUME; VOMITING; WOUND INFECTION;

AGED; CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; FEMALE; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; SERUM ALBUMIN; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84856952798     PISSN: 0720048X     EISSN: 18727727     Source Type: Journal    
DOI: 10.1016/j.ejrad.2010.12.058     Document Type: Article

References (47)

1. D.M. Parkin, F. Bray, J. Ferlay, and Pisani P Estimating the world cancer burden: Globocan 2000 Int J Cancer 94 2001 153 156
2. H.B. El-Serag, and Mason AC Rising incidence of hepatocellular carcinoma in the United States N Engl J Med 340 1999 745 750
3. K. Okuda, H. Obata, Y. Nakajima, T. Ohtsuki, N. Okazaki, and Ohnishi K Prognosis of primary hepatocellular carcinoma Hepatology 4 1 Suppl 1984 3S 6S
4. S.T. Fan, I.O. Ng, R.T. Poon, C.M. Lo, C.L. Liu, and Wong J Hepatectomy for hepatocellular carcinoma: the surgeon's role in long-term survival Arch Surg 134 1999 1124 1130
5. H.B. El-Serag, J.A. Marrero, L. Rudolph, and Reddy KR Diagnosis and treatment of hepatocellular carcinoma Gastroenterology 134 2008 1752 1763
6. K. Okuda, T. Ohtsuki, and H. Obata Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients Cancer 56 1985 918 928
7. F.L. Greene, D.L. Page, and Fleming ID Liver including intrahepatic bile ducts American Joint Committee on cancer staging manual 2002 Springer-Verlag New York
8. J. Bruix, and Llovet JM Prognostic prediction and treatment strategy in hepatocellular carcinoma Hepatology 35 2002 519 524
9. J.A. Marrero, R.J. Fontana, and A. Barrat Prognosis of hepatocellular carcinoma: comparison of 7 staging systems in an American cohort Hepatology 41 2005 707 716
10. I. Levy, and Sherman M Staging of hepatocellular carcinoma: assessment of the CLIP. Okuda, and Child-Pugh staging systems in a cohort of 257 patients in Toronto Gut 50 2002 881 885
11. J. Bruix, and M. Sherman Management of hepatocellular carcinoma Hepatology 42 2005 1208 1236
12. O. Matsui, M. Kadoya, and J. Yoshikawa Small hepatocellular carcinoma: treatment with subsegmental transcatheter arterial embolization Radiology 188 1993 79 83
13. M.Y. Hsieh, S.C. Chen, and S.N. Lu Treatment of hepatocellular carcinoma smaller than 5 cm by transcatheter arterial chemoembolization Kaohsiung J Med Sci 12 1996 274 278
14. H.S. Lee, K.M. Kim, and J.H. Yoon Therapeutic efficacy of transcatheter arterial chemoembolization as compared with hepatic resection in hepatocellular carcinoma patients with compensated liver function in a hepatitis B virus-endemic area: a prospective cohort study J Clin Oncol 20 2002 4459 4465
15. J. Bruix, M. Sherman, and J.M. Llovet Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona- 2000 EASL conference European Association for the Study of the Liver J Hepatol 35 2001 421 430
16. M. Makuuchi, T. Kosuge, and T. Takayama Surgery for small liver cancers Semin Surg Oncol 9 1993 298 304
17. C.B. Hsieh, C.Y. Yu, and C. Tzao Prediction of the risk of hepatic failure in patients with portal vein invasion hepatoma after hepatic resection Eur J Surg Oncol 32 2006 72 76
18. J.H. Pringle Notes on the arrest of hepatic hemorrhage due to trauma Ann Surg 48 1908 541 549
19. C.H. Cha, L. Ruo, and Y. Fong Resection of hepatocellular carcinoma in patients otherwise eligible for transplantation Ann Surg 238 2003 315 321
20. N. Shimozawa, and Hanazaki K Longterm prognosis after hepatic resection for small hepatocellular carcinoma J Am Coll Surg 198 2004 356 365
21. F. Yoshimi, T. Nagao, and S. Inoue Comparison of hepatectomy and transcatheter arterial chemoembolization for the treatment of hepatocellular carcinoma: necessity for prospective randomized trial Hepatology 16 1992 702 706
22. J.P. Bronowicki, K. Boudjema, and L. Chone Comparison of resection, liver transplantation and transcatheter oily chemoembolization in the treatment of hepatocellular carcinoma J Hepatol 24 1996 293 300
23. Y.H. Huang, J.C. Wu, and G.Y. Chau Supportive treatment, resection and transcatheter arterial chemoembolization in resectable hepatocellular carcinoma: an analysis of survival in 419 patients Eur J Gastroenterol Hepatol 11 1999 315 321
24. A. Guglielmi, A. Ruzzenente, and A. Valdegamberi Radiofrequency ablation versus surgical resection for the treatment of hepatocellular carcinoma in cirrhosis J Gastrointest Surg 12 2008 192 198
25. M. Vivarelli, A. Guglielmi, and A. Ruzzenente Surgical resection versus percutaneous radiofrequency ablation in the treatment of hepatocellular carcinoma on cirrhotic liver Ann Surg 240 2004 102 107
26. M. Sakon, H. Nagano, and S. Nakamori Intrahepatic recurrences of hepatocellular carcinoma after hepatectomy: analysis based on tumor hemodynamics Arch Surg 137 2002 94 99
27. S. Sumie, R. Kuromatsu, and K. Okuda Microvascular invasion in patients with hepatocellular carcinoma and its predictable Clinicopathological factors Ann Surg Oncol 15 2008 1375 1382
28. J.P. Bronowicki, D. Vetter, and F. Dumas Transcatheter oily chemoembolization for hepatocellular carcinoma. A 4-year study of 127 French patients Cancer 74 1994 16 24
29. B. Sangro, M. Herráiz, and M.A. Martínez-González Prognosis of hepatocellular carcinoma in relation to treatment: a multivariate analysis of 178 patients from a single European institution Surgery 124 1998 575 583
30. C. Cammà, F. Schepis, and A. Orlando Transarterial chemoembolization for unresectable hepatocellular carcinoma: meta-analysis of randomized controlled trials Radiology 224 2002 47 54
31. J.M. Llovet, M.I. Real, and X. Montaña Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial Lancet 359 2002 1734 1739
32. C.M. Lo, H. Ngan, and W.K. Tso Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma Hepatology 35 2002 1164 1171
33. T. Kanematsu, T. Matsumata, and K. Shirabe A comparative study of hepatic resection and transcatheter arterial embolization for the treatment of primary hepatocellular carcinoma Cancer 71 1993 2181 2186
34. L.H. Blumgart Surgery of the liver, biliary tract, and pancreas fourth ed. 2007 Saunders Philadelphia 1218
35. O. Matsui, S. Miyayama, and J. Sanada Interventional oncology: new options for interstitial treatments and intravascular approaches: superselective TACE using iodized oil for HCC: rationale, technique and outcome J Hepatobiliary Pancreat Sci 17 2010 407 409
36. J. Kenji, I. Hyodo, and M. Tanimizu Total necrosis of hepatocellular carcinoma with a combination therapy of arterial infusion of chemotherapeutic lipiodol and transcatheter arterial embolization: report of 14 cases Semin Oncol 24 1997 S71 S80
37. O. Matsui, M. Kadoya, J. Yoshikawa, T. Gabata, T. Takashima, and Demachi H Subsegmental transcatheter arterial embolization for small hepatocellular carcinomas: local therapeutic effect and 5-year survival rate. Cancer Chemother Pharmacol 33 Suppl 1994 S84 S88
38. J.W. Chung, J.H. Park, J.K. Han, B.I. Choi, T.K. Kim, and Han MC Transcatheter oily chemoembolization of the inferior phrenic artery in hepatocellular carcinoma: the safety and potential therapeutic role J Vasc Interv Radiol 9 1998 495 500
39. L.F. Cheng, K.F. Ma, W.C. Fan, A.W. Yung, T.M. Li, and Wong CS Hepatocellular carcinoma with extrahepatic collateral arterial supply J Med Imaging Radiat Oncol 54 2010 26 34
40. H. Lau, S.T. Fan, I.O. Ng, and Wong J Long term prognosis after hepatectomy for hepatocellular carcinoma: a survival analysis of 204 consecutive patients Cancer 83 1998 2302 2311
41. R.T. Poon, S.T. Fan, I.O. Ng, C.M. Lo, C.L. Liu, and Wong J Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma Cancer 89 2000 500 507
42. C.T. Lin, K.F. Hsu, and T.W. Chen Comparing hepatic resection and transarterial chemoembolization for Barcelona Clinic Liver Cancer (BCLC) stage B hepatocellular carcinoma: change for treatment of choice? World J Surg 34 2010 2155 2161
43. G.C. Sotiropoulos, N. Drühe, and G. Sgourakis Liver transplantation, liver resection, and transarterial chemoembolization for hepatocellular carcinoma in cirrhosis: which is the best oncological approach? Dig Dis Sci 54 2009 2264 2273
44. J. Bruix, A. Castells, and J. Bosch Surgical resection of hepatocellular carcinoma in cirrhotic patients: prognostic value of preoperative portal pressure Gastroenterology 111 1996 1018 1022
45. G. N'Kontchou, A. Mahamoudi, and M. Aout Radiofrequency ablation of hepatocellular carcinoma: long-term results and prognostic factors in 235 Western patients with cirrhosis Hepatology 50 2009 1475 1483
46. T. Livraghi, F. Meloni, and M. Di Stasi Sustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis: is resection still the treatment of choice? Hepatology 47 2008 82 89
47. A.O. Chan, M.F. Yuen, C.K. Hui, W.K. Tso, and C.L. Lai A prospective study regarding the complications of transcatheter intraarterial Lipiodol chemoembolization in patients with hepatocellular carcinoma Cancer 94 2002 1747 1752